Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents

Ne, E; Crespo, R; Izquierdo-Lara, R; Rao, S; Kocer, S; Gorska, A; van Staveren, T; Kan, TW; van de Vijver, D; Dekkers, D; Rokx, C; Moulos, P; Hatzis, P; Palstra, RJ; Demmers, J; Mahmoudi, T

Mahmoudi, T (通讯作者),Erasmus MC, Dept Biochem, Ee622 POB 2040, NL-3000CA Rotterdam, Netherlands.;Mahmoudi, T (通讯作者),Erasmus MC, Dept Pathol, Rotterdam, Netherlands.;Mahmoudi, T (通讯作者),Erasmus MC, Dept Urol, Rotterdam, Netherlands.

NUCLEIC ACIDS RESEARCH, 2022; 50 (10): 5577

Abstract

A major pharmacological strategy toward HIV cure aims to reverse latency in infected cells as a first step leading to their elimination. While the unb......

Full Text Link